Evidence map›Paper›PMID 23464850›Full record

ArticleHPB : the official journal of the International Hepato Pancreato Biliary Association2014

Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.

Jean Robert Delpero, Philippe Bachellier, Nicolas Regenet, Yves Patrice Le Treut, François Paye, Nicolas Carrere, Alain Sauvanet, Aurélie Autret, Olivier Turrini, Geneviève Monges-Ranchin and 1 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in HPB : the official journal of the International Hepato Pancreato Biliary Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07547033 (Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy), which is not on this map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07547033 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2026 to 2031Enrolled150ConditionsPancreatic Adenocarcinoma, Pancreatic Head CancerArmsSMA-first pancreaticoduodenectomy using either right posterior or anterior approach. SMA identified and isolated with peri-adventitial dissection before any irreversible section., Conventional pancreaticoduodenectomy without prior isolation of the SMA, antero-posterior approach of the uncinate process after pancreatic section.
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. What do surgeons need to know about the mesopancreas.Langenbeck's archives of surgery · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jean Robert DelperoDepartment of Surgery, Institute Paoli Calmettes, Marseille, France.
Philippe Bachellier
Nicolas Regenet
Yves Patrice Le Treut
François Paye
Nicolas Carrere
Alain Sauvanet
Aurélie Autret
Olivier Turrini
Geneviève Monges-Ranchin
Jean Marie Boher

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to determine the impact of a standardized pathological protocol on resection margin status after pancreaticoduodenectomy (PD) for ductal adenocarcinoma.

methodsA total of 150 patients operated during 2008-2010 were included in a prospective multicentre study using a 'quality protocol'. Multicolour inking by the surgeon identified three resection margins: the portal vein-superior mesenteric vein margin (PV-SMVm) or mesenterico-portal vein groove; the superior mesenteric artery margin (SMAm), and the posterior margin. Resection margins were stratified by 0.5-mm increments (range: 0-2.0 mm). Pancreatic neck, bile duct and intestinal margins were also analysed. Correlations between histopathological factors and survival in the 0-mm resection margin group were analysed.

resultsThirty-six patients (24%) had a PV-SMV resection (PV-SMVR). An analysis of resections categorized according to margin distances of 0 mm, <1.0 mm, <1.5 mm and <2.0 mm confirmed R1 resections in 35 (23%), 91 (61%), 94 (63%) and 107 (71%) patients, respectively. The most frequently invaded resection margin was the PV-SMVm (35% of all patients) and PV-SMVR was the only factor correlated with a higher risk for at least one 0-mm positive resection margin on multivariate analysis (P < 0.001). Two-year progression-free survival (PFS) and median PFS time in patients with R0 and R1 resections (at 0 mm), respectively, were 42.0% and 26.5%, and 19.5 months and 10.5 months, respectively (P = 0.02). A positive PV-SMVm and SMAm had significant impact on PFS, whereas a positive posterior margin had no impact.

conclusionsPancreaticoduodenectomy requiring PV-SMVR was associated with a higher risk for R1 resection. The standardization of histopathological analysis has a clinically relevant impact on PFS data.

Indexed as

PancreaticoduodenectomyAdultAgedAged, 80 and overCarcinoma, Pancreatic DuctalChi-Square DistributionDisease-Free SurvivalDisease ProgressionFemaleFranceHumansKaplan-Meier EstimateMaleMesenteric Artery, SuperiorMesenteric VeinsMiddle Aged

Identifiers

PMID23464850
PMCPMC3892311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.